ViCentra B.V

Utrecht, Utrecht, Netherlands · Biotechnology, Health Care, Mobile · 165 employees

ViCentra B.V. is the company behind Kaleido, one of the world's smallest, lightest, and most precise insulin patch pump and automated insulin delivery (AID) system.

Funding history

Series series d — $13.0M — Jan 2026
Series series d — $85.0M — Sep 2025

Recent signals

Jan 29, 2026: ViCentra Appoints Reman McDonagh as Vice President, Global Marketing
Jan 08, 2026: Raised $13.0M in Series series d
Sep 03, 2025: Raised $85.0M in Series series d
Feb 26, 2025: ViCentra Appoints Tom Arnold as Chief Executive Officer

See plans & pricing → Track ViCentra B.V’s funding, hiring, and signals — with verified contacts — on Fundz.